Chronic obstructive pulmonary disease (COPD), the frequently fatal pathology of the
respiratory tract, accounts for half a billion cases globally. COPD manifests via chronic …

Chronic diseases are persistent health conditions that affect our quality of life, increase
morbidity and mortality, and are a global challenge. Further, the increasing prevalence of …

目前, 慢性阻塞性肺疾病(COPD) 是世界第三大死因, 仅次于缺血性心脏病和卒中. 但面对COPD
这个可防, 可治的重大公共卫生问题, 我国临床诊疗仍有诸多不足, 如对患者教育不够, 随访缺失 …

Chronic obstructive pulmonary disease (COPD) is a complex condition with pathophysiology
and clinical characteristics that vary in presence and severity between patients (1). This …

In recent years, personalized or precision medicine has made effective inroads into the
management of diseases, including respiratory diseases. The route to implementing this …

Pharmacological treatment for chronic obstructive pulmonary disease (COPD) aims to
alleviate symptoms and reduce the future risk of events such as exacerbations, disease …

COPD is a clinically heterogeneous syndrome characterized by injury to airways, airspaces,
and lung vasculature and usually caused by tobacco smoke and/or air pollution exposure …

Monocytes were critical cells in the innate immune system. Monocyte recruitment to the
lungs is a crucial process of pathophysiology in chronic obstructive pulmonary disease …

Background Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory
disease characterized by neutrophils airway infiltration. It is currently known that Interleukin …

Asthma is a generalized term that describes a scope of distinct pathologic phenotypes of
variable severity, which share a common complication of reversible airflow obstruction …